Cutera, Inc. (NASDAQ:CUTR) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition.

On April 20, 2017, Cutera, Inc. (the “Company”) issued a press release disclosing preliminary, un-audited, revenue and certain selected financial data for the first quarter of 2017. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 17, 2017, Ronald J. Santilli, Executive Vice President and Chief Financial Officer, notified the Company that he intends to transition out from his position in the Company. It is expected that Mr. Santilli will remain an employee of the Company until the appointment of his successor, and that he will assist with transition matters thereafter.

Additional information about the management change described above is included in the Company’s press release issued on April 20, 2017, which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

99.1 Press Release dated April 20, 2017 announcing preliminary financial results for first quarter of 2017 and planned management change.

About Cutera, Inc. (NASDAQ:CUTR)

Cutera, Inc. is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers. Each of its laser and other energy-based platforms consists of one or more hand pieces and a console that incorporates a universal graphical user interface, a laser or other energy-based module, control system software and high voltage electronics. enlighten is a dual wavelength (1,064 nanometer + 532 nanometer) and dual pulse duration (750 picosecond (ps) and 2 nanosecond (ns)) laser system. excel V is a vascular and benign pigmented lesion treatment platform designed for the core-market of dermatologists and plastic surgeons.

Cutera, Inc. (NASDAQ:CUTR) Recent Trading Information

Cutera, Inc. (NASDAQ:CUTR) closed its last trading session down -0.15 at 20.00 with 58,160 shares trading hands.